![](https://irei.com/wp-content/uploads/2021/04/940_2021_people_gathering.jpg)
Press Releases and Story Ideas
Upload your latest press release or suggest a story idea to our editorial team.
Research | Jul 26, 2024
According to Savills in its latest quarterly Prime Office Costs report, gross prime office rents in major cities around the world have risen 3 percent in the past year (second quarter 2023 to second quarter 2024) while tenants’ all-in net effective costs (rent plus fit-out costs) have risen 3.8 percent, as the structural trend toward seeking high-quality, premium office space continues. London (West End), Hong Kong, and New York (Midtown) remain the top three locations of the 35 markets Savills examined, compared to first quarter 2024.
Investors | Jul 26, 2024
SCALE Lending, the debt-financing arm of Slate Property Group, has made an initial partnership with Harel Finance to support the deployment of construction and bridge loans on multifamily and condo projects in the United States.
Transactions | Jul 26, 2024
Cohen & Steers Income Opportunities REIT, Inc. (CNSREIT) has acquired Des Peres Corners, a grocery-anchored shopping center in Des Peres, Mo., with Phillips Edison & Co., Inc., (PECO).
Investors | Jul 26, 2024
CBRE has announced an agreement with UBS Asset Management’s U.S. real estate and private markets business to provide a range of fund administration and related services for its U.S. real estate and farmland assets.
Research | Jul 26, 2024
Demand for data center capacity will remain strong for at least the next five years, predicts a July 23 report from Moody’s Ratings, helping REITs Digital Realty Trust and Equinix to grow their portfolios and uphold key credit metrics.
Investors | Jul 25, 2024
Barings and Spanish real estate group Salas have acquired two build-to-sell assets in the greater Barcelona region in the first deals for a joint venture partnership formed with the potential to deploy more than €100 million ($108 million).
Research | Jul 25, 2024
The United Kingdom saw a 77 percent year-on-year jump in venture capital funding for the pharma and biotech sectors in first half 2024, according to Knight Frank, with lab and office demand likely to increase as a result.